I’m going to take a look at rare diseases from the economic lens of three market failures. Negative Externalities Rare diseases impose significant negative externalities on society and healthcare systems. Consider this statistic – In Europe about 30 million people (1 in 17) suffer from a debilitating rare disease Now take a minute to review…